The SCL/TAL1 gene: Roles in normal and malignant haematopoiesis

BioEssays

Volumn 19, Issue 7, 1997, Pages 607-613

  Robb, Lorraine ^a   Begley, C Glenn ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MUS MUSCULUS;

EID: 0031194883     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.950190711     Document Type: Review

References (69)

1. Mellentin, J. D., Smith, S. D. and Cleary, M. L. (1989). lyl-1, a novel gene altered by a chromosomal translocation in a T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif. Cell 58, 77-83.
2. Xia, Y. et al. (1991). TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia. Proc. Natl Acad. Sci. USA 88, 11416-11420.
3. Begley, C. G. et al. (1992). Molecular characterization of NSCL a 'helix-loop-helix' protein expressed in the developing nervous system. Proc. Natl Acad. Sci. USA 89, 38-42.
4. Hsu, H.-L., Cheng, J.-T., Chen, Q. and Baer, R. (1991). Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins. Mol. Cell. Biol. 11, 3037-3042.
5. Hsu, H.-L., Wadman, I. and Baer, R. (1994). Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic cells. Proc. Natl Acad. Sci. USA 91, 3181-3185.
6. Hsu, H.-L. et al. (1993). Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol. Cell. Biol. 14, 1256-1265.
7. Valge-Archer, V. E. et al. (1994). The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. Proc. Natl Acad. Sci. USA 91, 8617-8621.
8. Voronova, A. F. and Lee, F. (1994). The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation. Proc. Natl Acad. Sci. USA 91, 5952-5956.
9. Condorelli, G. L. et al. (1995). Coodordinate expression and developmental role of Id2 protein and TAL1/E2A heterodimer in eryhtroid progenitor differentiation. Blood 86, 164-175.
10. Hsu, H.-L., Wadman, I., Tsan, J. T. and Baer, R. (1994). Positive and negative transcriptional control by the TAL1 helix-loop-helix protein. Proc. Natl Acad. Sci. USA 91, 5947-5951.
11. Sanchez-Garcia, I. and Rabbitts, T. H. (1994). Transcriptional activation by TAL-1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities. Proc. Natl Acad. Sci. USA 91, 7869-7873.
12. Goldfarb, A. N. and Lewandowska, K. (1995). Inhibition of cellular differentiation by the SCL/tal oncoprotein: transcriptional repression by an Id-like mechanism. Blood 85, 465-471.
13. Doyle, K., Zhang, Y., Baer, R. and Bina, M. (1994). Distinguishable patterns of protein-DNA interactions involving complexes of basic helix-loop-helix proteins. J. Biol. Chem. 269, 12099-12105.
14. Hofmann, T. J. and Cole, M. D. (1996). The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation. Oncogens 13, 617-624.
15. Cheng, J.-T., Hsu, H.-L., Hwang, L.-Y. and Baer, R. (1993). Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues. Oncogene 8, 677-683.
16. Cheng, J.-T., Cobb, M. H. and Baer, R. (1993). Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1. Mol. Cell. Biol. 13, 801-808.
17. Prasad, K. S. S. and Brandt, S. J. (1995). Phosphorylation of TAL1/SCL protein kinase by cAMP dependent protein kinase has selective effects on DNA binding. Blood Abstr. 1200.
18. Royer-Pokora, B., Loos, U. and Ludwig, W. D. (1991). Ttg-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). Oncogene 6, 1887-1893.
19. Boehm, T., Foroni, L., Kaneko, Y., Perutz, M. F. and Rabbits, T. H. (1991). The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc. Natl Acad. Sci. USA 88, 4367-4371.
20. Wadman, I. et al. (1994). Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO J 13, 4831-4839.
21. Osada, H., Grutz, G., Axelson, H., Forster, A. and Rabbitts, T. H. (1995). Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1. Proc. Natl Acad. Sci. USA 92, 9585-9589.
22. Tsang, A. P., Visvader, J. E., Turner, C. A., Fujiwara, Y., Crossley, M. and Orkin, S. H. (1996). FOG-1 (friend of GATA-1): a candidate cofactor for the transcription factor GATA-1 in erythroid and megakaryocytic lineages. Blood Abstr. 553.
23. Begley, C. G., Aplan, P. D., Denning, S. M., Haynes, B. F., Waldmann, T. A. and Kirsch, I. R. (1989). The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc Natl Acad Sci USA 86, 10128-10132.
24. Finger, L. R. et al. (1989). Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc. Natl Acad. Sci. USA 86, 5039-5043.
25. Chen, Q. et al. (1990). The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J. 9, 415-424.
26. Carroll, A. J. et al. (1990). The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: A Pediatric Oncology Group study. Blood 76, 1220-1224.
27. Bernard, O. et al. (1991). Two site-specific deletions and t(1:14) translocation restricted to human T-cell acute leukemias disrupt the 5′ part of the tal-1 gene. Oncogene 6, 1477-1488.
28. Robb, L. and Begley, C. G. (1996). The helix-loop-helix gene scl: implicated in T-cell acute lymphoblastic leukaemia and in normal haematopoietic development. Int. J. Biochem. Cell Biol. 28, 609-618.
29. Aplan, P. D., Lombardi, D. P., Ginsberg, A. M., Cossman, J., Bertness, V. and Kirsch, I. R. (1990). Disruption of the human SCL locus by 'illegitimate' V-(D)-J recombinase activity. Science 250, 1426-1429.
30. Brown, L. et al. (1990). Site specific recombination of the tal-1 gene is a common occurrence in the human T cell leukemia. EMBO J. 9, 3343-3351.
31. Aplan, P. D., Lombardi, D. P., Reaman, G. H., Sather, H. N., Hammond, G. D. and Kirsch, I. R. (1992). Involvement of the putative hemapoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Blood 79, 1327-1333.
32. Breit, T. M., Mol, E. J., Wolvers-Tettero, T. I., Ludwig, W. D., van Wering, E. R. and van Dongen, D. J. (1993). Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T-cell receptor α/β lineage: T cell receptor δ gene deletion mechanism affects multiple genes. J. Exp. Med. 177, 965-977.
33. Stock, W. et al. (1995). Low incidence of TAL1 gene rearrangements in adult acute lymphoblastic leukemia: a cancer and leukemia group B study. Clin. Cancer Res. 1, 459-463.
34. Macintyre, E. A., Smit, L., Ritz, J., Kirsch, I. R. and Strominger, J. L. (1992). Disruption of the SCL locus in T-lymphoid malignancies correlates with commitment to the T-cell receptor αβ lineage. Blood 80, 1511-1520.
35. Jonsson, O. G., Kitchens, R. L., Baer, R. J., Buchanan, G. R. and Smith, R. G. (1991). Rearrangements of the tal-1 locus as clonal markers for T cell acute lymphoblastic leukemia. J. Clin. Invest. 87, 2029-2035.
36. Bash, R. et al. (1995). Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A Pediatric Oncology Group Study. Blood 86, 666-676.
37. Elwood, N. J., Cook, W. D., Metcalf, D. and Begley, C. G. (1993). SCL, the gene implicated in human T-cell leukaemia, is oncogenic in a murine T-lymphocyte line. Oncogene 8, 3093-3101.
38. Robb, L., Rasko, J. E. J., Bath, M. L., Strasser, A. and Begley, C. G. (1995). scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice. Oncogene 10, 205-209.
39. Larson, R. C. et al. (1996). Protein dimerization between Lmo2 (Rbtn2) and Tall alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J. 15, 1021-1027.
40. Larson, R. C. et al. (1994). T cell tumours of disparate phenotype in mice transgenic for Rbtn-2. Oncogene 9, 3675-3681.
41. Kelliher, M. A., Seldin, D. C. and Leder, P. (1996). Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIα. EMBO J. 15, 5160-5166.
42. Condorelli, G. L. et al. (1996). T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice. Cancer Res. 56, 5113-5119.
43. Green, A. R., Salvaris, E. and Begley, C. G. (1991) Erythroid expression of the 'helix-loop-helix' gene SCL. Oncogene 6, 475-479.
44. Visvader, J. E., Begley, C. G. and Adams, J. M. (1991). Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system. Oncogene 6, 195-204.
45. Mouthon, M.-A., Bernard, O., Mitjavila, M.-T., Romeo, P.-H., Vainchenker, W. and Mathieu-Mahul, D. (1993). Expression of tal-1 and GATA binding proteins during human hematopoiesis. Blood 81, 647-655.
46. Pevny, L. et al. (1991). Erythroid differentiation in chimeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349, 257-260.
47. Aplan, P. D., Nakahara, K., Orkin, S. H. and Kirsch, I. R. (1992). The SCL gene product: a positive regulator of erythroid differentiation. EMBO J. 11, 4073-4081.
48. Lecointe, N. et al. (1994). GATA-and SP1-binding sites are required for full activity of the tissue specific promoter of the tal-1 gene. Oncogene 9, 2623-2632.
49. Kallianpur, A. R., Jordan, J. E. and Brandt, S. J. (1994). The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood 83, 1200-1208.
50. Green, A. R., Lints, T., Visvader, J., Harvey, R. and Begley, C. G. (1992) SCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brain. Oncogene 7, 653-660.
51. Chiba, T. et al. (1993). Induction of erythroid-specific gene expression in lymphoid cells. Proc. Natl Acad. Sci. USA 90, 11593-11597.
52. Cross, M. A., Heyworth, C. M., Murrell, A. M., Bockamp, E.-O., Dexter, T. M. and Green, A. R. (1994). Expression of lineage restricted transcription factors precedes lineage specific differentiation in a multipotent haemopoietic progenitor cell line. Oncogens 9, 3013-3016.
53. Prasad, K. S. K., Jordan, J. E., Koury, M. J., Bondurant, M. C. and Brandt, S. J. (1995). Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation of its protein products. J. Biol. Chem. 270, 11603-11611.
54. Murrell, A. M. et al. (1995). Discordant regulation of SCL/TAL-1 mRNA and protein during erythroid differentiation. Oncogens 11, 131-139.
55. Green, A. R., Rockman, S., DeLuca, E. and Begley, C. G. (1993). Induced myeloid differentiation of K562 cells with downregulation of erythroid and megakaryocytic transcription factors: a novel experimental system for hemopoietic lineage restriction. Exp. Hematol. 21, 525-531.
56. Tanigawa, T. et al. (1993). The SCL gene product is regulated by and differentially regulates cytokine responses during myeloid leukemic cell differentiation. Proc. Natl Acad. Sci. USA 90, 7864-7868.
57. Hoang, T. et al. (1996). Opposing effects of the basic helix-loop-helix transcription factor SCL on erythroid and monocytic differentiation. Blood 87, 102-111.
58. Cheng, T., Shen, H., Giokas, D., Gere, J., Tenen, D. G. and Scadden, D. T. (1996). Temporal mapping of gene expression levels during the differentiation of individual primary hematopoietic cells. Proc. Natl Acad. Sci. USA 93, 13158-13163.
59. Green, A. R., DeLuca, E. and Begley, C. G. (1991). Antisense SCL suppresses self-renewal and enhances spontaneous erythroid differentiation of the human leukaemic cell line K562. EMBO J. 10, 4153-4158.
60. Robb, L. et al. (1995). Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc. Natl Acad. Sci. USA 92, 7075-7079.
61. Shivdasani, R. A., Mayer, E. L. and Orkin, S. H. (1995). Absence of blood formation in mice the T-cell leukaemia oncoprotein tal-1/SCL. Nature 373, 432-434.
62. Warren, A. J., Colledge, W. H., Carlton, M. B. L., Evans, M. J., Smith, A. J. H. and Rabbitts, T. H. (1994). The oncogenic cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development. Cell 78, 45-57.
63. Porcher, C., Swat, W., Rockwell, K., Fujiwara, Y., Alt, F. W. and Orkin, S. H. (1996). The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell 86, 47-57.
64. Robb, L. et al. (1996). The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J. 15, 4123-4129.
65. Guillemot, F., Nagy, A., Auerbach, A., Rossant, J. and Joyner, A. L. (1994). Essential role of Mash-2 in extraembryonic development. Nature 371, 333-336.
66. Shalaby, F. et al. (1995). Failure of blood-island formation and vasculogenesis in flk-1-deficient mice. Nature 376, 62-66.
67. Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G. and Downing, J. R. (1996). AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321-330.
68. Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H. and Speck, N. A. (1996). Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl Acad. Sci. USA 93, 3444-3449.
69. Shivdasani, R. A. and Orkin, S. H. (1996). The transcriptional control of hematopoiesis. Blood 87, 4025-4039.